LFST
LifeStance Health Group, Inc. NASDAQ Listed Jun 10, 2021$8.98
+4.30%
vs $8.61
Mkt Cap $3.5B
52w Low $3.74
97.6% of range
52w High $9.11
50d MA $7.55
200d MA $6.64
P/E (TTM)
449.0x
EV/EBITDA
43.3x
P/B
2.3x
Debt/Equity
0.1x
ROE
0.6%
P/FCF
31.9x
RSI (14)
71.20
ATR (14)
$0.31
Beta
1.13
50d MA
$7.55
200d MA
$6.64
Avg Volume
4.7M
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
4800 N. Scottsdale Road · Scottsdale, AZ 85251 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 7.36 | +8.7% | +20.2% | -13.0% | -0.4% | +3.4% | +2.1% | — |
| Feb 25, 2026 | AMC | -0.00 | 0.03 | +3287.2% | 7.41 | -5.8% | -6.1% | +4.0% | -1.4% | +1.8% | +0.8% | — |
| Nov 6, 2025 | AMC | -0.01 | 0.00 | +128.0% | 6.25 | +1.9% | +0.6% | +2.2% | +0.6% | -0.5% | -2.0% | — |
| Aug 7, 2025 | AMC | -0.03 | -0.01 | +66.7% | 3.86 | +1.8% | +13.2% | +4.6% | +2.0% | +10.9% | +7.9% | — |
| May 7, 2025 | AMC | -0.04 | 0.00 | +104.5% | 5.51 | +0.9% | +5.4% | -1.4% | +2.1% | +0.3% | -2.2% | — |
| Feb 27, 2025 | AMC | -0.04 | -0.02 | +50.0% | 7.74 | +1.2% | +0.6% | +1.5% | +1.4% | +1.7% | -3.4% | — |
| Nov 7, 2024 | AMC | -0.07 | -0.02 | +71.4% | 7.68 | +0.4% | -4.2% | +0.4% | +0.1% | -2.4% | +0.1% | — |
| Aug 8, 2024 | AMC | -0.07 | -0.06 | +14.3% | 5.93 | -2.9% | -5.6% | -1.8% | +6.2% | -2.7% | +2.8% | — |
| May 9, 2024 | AMC | -0.09 | -0.06 | +33.3% | 7.12 | +0.8% | -3.7% | +4.5% | +3.1% | +1.4% | -1.6% | — |
| Feb 28, 2024 | AMC | -0.09 | -0.12 | -33.3% | 8.71 | +1.4% | -4.1% | -6.7% | -0.4% | -4.9% | -1.9% | — |
| Nov 8, 2023 | AMC | -0.07 | -0.17 | -142.9% | 5.82 | +0.7% | -3.4% | -0.2% | +0.7% | +9.9% | -1.4% | — |
| Aug 9, 2023 | AMC | -0.09 | -0.13 | -44.4% | 8.06 | +0.6% | +2.4% | -1.1% | -1.5% | -0.7% | -4.0% | — |
| May 10, 2023 | AMC | -0.11 | -0.09 | +18.2% | 8.26 | +1.7% | -0.2% | +3.6% | -1.1% | -1.9% | -1.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5 | Goldman | Initiates | Neutral | $9 | $7.64 | $7.56 | -1.0% | -3.0% | -0.9% | +4.4% | +2.6% | +9.5% |
| Mar 6 | Barclays | Maintains | Overweight → Overweight | — | $6.95 | $7.00 | +0.7% | -0.3% | -0.3% | -2.6% | -1.3% | -4.7% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $7.41 | $6.98 | -5.8% | -6.1% | +4.0% | -1.4% | +1.8% | +0.8% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.41 | $6.98 | -5.8% | -6.1% | +4.0% | -1.4% | +1.8% | +0.8% |
| Feb 26 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $7.41 | $6.98 | -5.8% | -6.1% | +4.0% | -1.4% | +1.8% | +0.8% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $7.07 | $7.17 | +1.4% | +1.6% | -1.0% | -2.5% | -5.6% | +4.4% |
| Dec 12 | BTIG | Maintains | Buy → Buy | — | $6.76 | $6.83 | +1.0% | +2.2% | +0.1% | -0.6% | +0.4% | +0.4% |
| Nov 7 | UBS | Maintains | Buy → Buy | — | $6.25 | $6.37 | +1.9% | +0.6% | +2.2% | +0.6% | -0.5% | -2.0% |
| Nov 6 | BTIG | Maintains | Buy → Buy | — | $4.81 | $5.34 | +11.0% | +29.9% | +0.6% | +2.2% | +0.6% | -0.5% |
| Aug 8 | UBS | Maintains | Buy → Buy | — | $3.86 | $3.93 | +1.8% | +13.2% | +4.6% | +2.0% | +10.9% | +7.9% |
| May 27 | UBS | Upgrade | Neutral → Buy | — | $5.49 | $6.10 | +11.1% | +10.4% | -0.3% | -2.2% | +0.5% | -1.0% |
| Dec 16 | Goldman Sachs | Upgrade | Neutral → Buy | — | $7.17 | $7.59 | +5.9% | +8.1% | -3.5% | -5.2% | -0.6% | +3.4% |
| Nov 11 | Barclays | Maintains | Underweight → Underweight | — | $7.36 | $7.40 | +0.5% | +0.4% | +0.1% | -2.4% | +0.1% | -1.2% |
| Aug 15 | UBS | Maintains | Neutral → Neutral | — | $5.68 | $5.81 | +2.3% | +2.8% | -3.3% | +2.8% | -1.5% | +1.0% |
| Aug 9 | Barclays | Maintains | Underweight → Underweight | — | $5.93 | $5.76 | -2.9% | -5.6% | -1.8% | +6.2% | -2.7% | +2.8% |
| Apr 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $5.71 | $5.71 | +0.0% | +2.8% | +4.1% | +1.0% | -0.2% | +0.6% |
| Mar 6 | Jefferies | Maintains | Buy → Buy | — | $7.38 | $7.42 | +0.5% | -1.9% | -0.3% | -0.1% | -1.7% | -3.0% |
| Mar 4 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.79 | $7.74 | -0.6% | -0.4% | -4.9% | -1.9% | -0.3% | -0.1% |
| Feb 29 | Barclays | Maintains | Underweight → Underweight | — | $8.71 | $8.83 | +1.4% | -4.1% | -6.7% | -0.4% | -4.9% | -1.9% |
| Nov 22 | Goldman Sachs | Maintains | Neutral → Neutral | — | $6.16 | $6.25 | +1.5% | +3.9% | +2.3% | +0.9% | +1.1% | +1.0% |
| Nov 17 | JP Morgan | Maintains | Neutral → Neutral | — | $6.12 | $6.17 | +0.8% | +0.8% | +0.5% | -0.6% | +3.9% | +2.3% |
| Aug 10 | JP Morgan | Maintains | Neutral → Neutral | — | $8.06 | $8.11 | +0.6% | +2.4% | -1.1% | -1.5% | -0.7% | -4.0% |
| Jul 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.74 | $8.74 | +0.0% | +0.5% | +6.3% | -0.9% | -0.2% | -1.3% |
| May 19 | Goldman Sachs | Maintains | Neutral → Neutral | — | $8.23 | $8.38 | +1.8% | +1.6% | -0.6% | -0.5% | -0.7% | -1.0% |
| May 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.26 | $8.40 | +1.7% | -0.2% | +3.6% | -1.1% | -1.9% | -1.0% |
| Jan 6 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $4.40 | $4.70 | +6.8% | +7.3% | +5.1% | +0.4% | +2.2% | +2.6% |
| Nov 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $6.12 | $6.28 | +2.6% | -3.9% | -5.1% | -8.8% | -2.2% | -0.6% |
| Nov 14 | TD Cowen | Maintains | Outperform → Outperform | — | $6.15 | $6.10 | -0.8% | -0.5% | -3.9% | -5.1% | -8.8% | -2.2% |
| Aug 22 | TD Cowen | Maintains | Outperform → Outperform | — | $6.68 | $6.52 | -2.4% | +1.6% | +4.9% | -1.3% | -1.7% | -5.4% |
| May 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.20 | $6.35 | +2.4% | -6.1% | +0.2% | +8.1% | +7.8% | -2.9% |
| Mar 21 | Goldman Sachs | Maintains | Neutral → Neutral | — | $9.34 | $9.20 | -1.5% | -4.3% | +5.4% | -0.3% | +3.6% | -1.1% |
| Mar 17 | UBS | Downgrade | Buy → Neutral | — | $10.12 | $9.55 | -5.6% | -5.5% | -2.3% | -4.3% | +5.4% | -0.3% |
| Dec 17 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $9.20 | $9.20 | +0.0% | +5.0% | +0.1% | +2.2% | +0.7% | +1.5% |
| Nov 9 | JP Morgan | Downgrade | Overweight → Neutral | — | $12.83 | $10.50 | -18.2% | -24.2% | +10.6% | -5.1% | +1.3% | +2.4% |
| Sep 10 | TD Cowen | Maintains | Outperform → Outperform | — | $15.30 | $15.65 | +2.3% | +6.3% | -5.0% | +1.4% | -2.0% | +2.9% |
| Aug 16 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $13.45 | $13.04 | -3.0% | +2.8% | -3.3% | +0.1% | -0.9% | -3.0% |
| Jul 6 | UBS | Maintains | Buy → Buy | — | $27.60 | $27.88 | +1.0% | +1.6% | +3.2% | -4.5% | +4.5% | -2.4% |
| Jul 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $27.60 | $27.88 | +1.0% | +1.6% | +3.2% | -4.5% | +4.5% | -2.4% |
| Jul 6 | William Blair | Maintains | Outperform → Outperform | — | $27.60 | $27.88 | +1.0% | +1.6% | +3.2% | -4.5% | +4.5% | -2.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Bessler Robert | — | Sell | 287,517 | $8.02 | $2.3M | 986,931 | -3.04% | -2.86% |
| May 12, 2026 | Shuey Eric | — | Sell | 243,362 | $8.02 | $2.0M | 867,562 | -3.04% | -2.86% |
| May 12, 2026 | BLACK DARREN M. | — | Sell | 5,899,661 | $8.02 | $47.3M | 23,310,115 | -3.04% | -2.86% |
| May 12, 2026 | TPG GP A, LLC10% | — | Sell | 28,281,943 | $8.02 | $226.8M | 111,744,614 | -3.04% | -2.86% |
| May 7, 2026 | Bessler Robert | — | Sell | 37,500 | $8.55 | $321K | 1,236,948 | +3.39% | +1.96% |
| Apr 24, 2026 | Bessler Robert | — | Sell | 31,074 | $7.05 | $219K | 1,391,246 | +5.50% | -3.45% |
| Apr 24, 2026 | Bessler Robert | — | Sell | 31,073 | $7.05 | $219K | 1,274,448 | +5.50% | -3.45% |
| Apr 23, 2026 | Bessler Robert | — | Sell | 3,876 | $7.00 | $27K | 1,305,521 | +5.50% | -3.45% |
8-K
Unknown — 8-K Filing
LFST awarded $1.5M in equity grants to an executive, indicating confidence in leadership stability while potentially diluting existing shareholders' ownership percentages.
Mar 11
8-K
LifeStance Health Group, Inc. -- 8-K Filing
LifeStance Health Group obtained legal counsel opinion from Ropes Gray LLP regarding an unspecified transaction, likely involving securities issuance or corporate action compliance.
Mar 2
8-K · 5.02
!!! Very High
LifeStance Health Group, Inc. -- 8-K 5.02: Executive Change
Kenneth Burdick's transition from Executive Chairman to non-executive Chairman at LifeStance Health indicates a planned leadership restructuring without operational disagreement, potentially signaling management confidence and continuity.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 58,685,480 | $374M | Added | Mar 2026 |
| 2 | Summit Partners L P | 29,209,776 | $186M | Reduced | Mar 2026 |
| 3 | Silversmith Partners I Gp, Llc | 14,324,197 | $101M | New | Dec 2025 |
| 4 | Vanguard Portfolio Management Llc | 9,682,305 | $62M | New | Mar 2026 |
| 5 | Jennison Associates Llc | 7,385,413 | $52M | Reduced | Dec 2025 |
| 6 | Vanguard Capital Management Llc | 7,908,159 | $50M | New | Mar 2026 |
| 7 | Morgan Stanley | 6,610,824 | $47M | Added | Dec 2025 |
| 8 | Citadel Advisors Llc | 3,850,026 | $25M | Added | Mar 2026 |
| 9 | Principal Financial Group Inc | 3,215,320 | $23M | Added | Dec 2025 |
| 10 | First Eagle Investment Management, Llc | 3,220,932 | $21M | Added | Mar 2026 |
| 11 | Qube Research & Technologies Ltd | 3,188,657 | $20M | Added | Mar 2026 |
| 12 | Barclays Plc | 2,765,692 | $18M | Reduced | Mar 2026 |
| 13 | Nuveen, Llc | 2,210,932 | $14M | Reduced | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 1,994,027 | $13M | Added | Mar 2026 |
| 15 | Millennium Management | 1,899,049 | $12M | Added | Mar 2026 |
| 16 | Woodline Partners Lp | 1,815,221 | $12M | Added | Mar 2026 |
| 17 | Northern Trust Corp | 1,534,853 | $10M | Added | Mar 2026 |
| 18 | Susquehanna International Group, Llp | 1,454,392 | $9M | Added | Mar 2026 |
| 19 | First Trust Advisors Lp | 1,066,191 | $7M | Added | Mar 2026 |
| 20 | Aqr Capital Management Llc | 988,973 | $6M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.48B
Enterprise Value
$3.41B
P/E (TTM)
449.00x
Forward P/E
122.85x
PEG Ratio
-2.34x
P/B
2.28x
P/S
2.47x
P/FCF
31.92x
EV/EBITDA
43.32x
Shares Out
391.1M
Financials (TTM)
Revenue
$1.42B
Net Income
$9.7M
EBITDA
$78.8M
Free Cash Flow
$110.0M
Op Cash Flow
$146.2M
EPS Basic
$0.03
EPS Diluted
$0.02
EPS Forward
$0.07
Gross Margin
28.5%
Op Margin
1.8%
Net Margin
0.7%
Balance Sheet
Total Assets
$2.20B
Total Liab.
$682.9M
Total Equity
$1.52B
Cash
$248.6M
LT Debt
$148.6M
Book Value/Sh
$3.94
Debt/Equity
0.13x
Current Ratio
1.65
Quick Ratio
1.65
Returns & Growth
ROE
0.6%
ROA
0.4%
ROIC
1.0%
Rev Growth YoY
+13.9%
EPS Growth YoY
+120.0%
Price Returns
2W
-2.3%
1M
+1.8%
3M
+6.5%
6M
+18.6%
12M
+29.8%
Technicals
52W High
$9.11
52W Low
$3.74
50d MA
$7.55
200d MA
$6.64
RSI (14)
71.20
ATR (14)
$0.31
Beta
1.13
Avg Volume
4.7M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$9.30
High
$11.00
Low
$8.00
Median
$9.00
Data updated apr 25, 2026 6:56pm
· Source: financialmodelingprep.com